Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 …
Moderna
-
-
Key Takeaways Shares of Moderna fell Friday after taking on steep losses a day earlier …
-
Key Takeaways The S&P 500 added 0.8% on Thursday, Sept. 12, 2024, extending its winning …
-
-
Key Takeaways Moderna shares fell Thursday morning after the COVID vaccine maker announced plans to …
-
Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared …
-
Key Takeaways The S&P 500 dropped 0.9% on Thursday, Aug. 22, as tech stocks faltered …
-
The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, …
-
-
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, …
-
Key Takeaways Moderna on Tuesday announced a $176 million federal grant to develop a bird …
-
-
BusinessHealth CareNews
Moderna, Merck cancer vaccine with Keytruda improved survival in trial
by adminModerna and Merck released more positive three-year data Monday on their experimental vaccine, given to …
-
Nikos Pekiaridis | Lightrocket | Getty Images The Food and Drug Administration on Friday approved …
- 1
- 2